During the past decade, Hospital de Merida conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 9 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Merida" #1 sponsor was "PETHEMA Foundation" with 4 trials, followed by "Fundación EPIC" with 3 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Merida" #1 collaborator was "Barcelona Clinic Hospital (HCB), Spain" with 1 trials as a collaborator, "Carlos III Health Institute (ISCIII), Spain" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Federation Francophone de Cancerologie Digestive" with 1 trials as a collaborator and "Fundació Clínic per a la Recerca Biomèdica (FCRB), Spain" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Merida" are "Coronary Artery Disease" (5 trials), "Multiple Myeloma" (3 trials), "Perioperative Care" (3 trials), "Postoperative Complications" (3 trials) and "Arthritis, Psoriatic" (2 trials). Many other conditions were trialed in "Hospital de Merida" in a lesser frequency.

Most popular intervention types in "Hospital de Merida" are "Drug" (20 trials), "Other" (6 trials), "Device" (3 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "ATRA" (1 trials), "Allergen extract (Phleum pratense)" (1 trials), "Allogenic Transplantation" (1 trials) and "Apremilast (CC-10004)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Merida" are 32 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital de Merida". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Hospital de Merida, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Merida, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".